Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
240 participants
INTERVENTIONAL
2018-02-02
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception
NCT03067272
Evaluation of the Safety and Efficacy of the ReLARC Inserter During the Insertion Procedure of GYNEFIX Intrauterine Copper Bearing Contraceptive Device with a Follow-up of 3 Years.
NCT05702281
PREMO Study: to Investigate Port REMoval Outcomes
NCT03948958
Tunneled Peripherally Inserted Central Catheter (PICC) in Adult Patients and Associated Outcomes
NCT06365528
Effectiveness of a Zinc Oxide Adhesive Securement Device in the Fixation of Midline and Peripherally Inserted Central Catheters in Hospitalized Adult Patients
NCT06770374
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FemBloc
Investigational device and procedure
FemBloc
Treatment with FemBloc for women who desire permanent birth control (female sterilization)
Control
Laparoscopic bilateral tubal sterilization
Laparoscopic bilateral tubal sterilization
Laparoscopic bilateral tubal sterilization for women who desire permanent birth control (female sterilization)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FemBloc
Treatment with FemBloc for women who desire permanent birth control (female sterilization)
Laparoscopic bilateral tubal sterilization
Laparoscopic bilateral tubal sterilization for women who desire permanent birth control (female sterilization)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sexually active with male partner
* For FemBloc Arm:
* Regular menstrual cycle for last 3 months or on hormonal contraceptives
* For Control Arm:
* Undergoing planned laparoscopic bilateral tubal sterilization
Exclusion Criteria
* Known or suspected pregnancy
* Prior tubal surgery, including sterilization attempt
* Prior endometrial ablation
* Presence, suspicion, or previous history of gynecologic malignancy
* Abnormal uterine bleeding requiring evaluation or treatment
* Scheduled to undergo concomitant intrauterine procedures at the time of procedure(s)
21 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Femasys Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sponsor
Role: STUDY_DIRECTOR
Medical Affairs & Clinical Development
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New Horizons Clinical Trials
Chandler, Arizona, United States
Stanford University
Stanford, California, United States
Altus Research Inc.
Lake Worth, Florida, United States
Rosemark Womencare Specialists
Idaho Falls, Idaho, United States
Women's Health Advantage
Fort Wayne, Indiana, United States
Rutgers, The State University of New Jersey
Newark, New Jersey, United States
Columbia University Medical Center
New York, New York, United States
Wake Research Associates, LLC
Raleigh, North Carolina, United States
University Hospitals Cleveland Medical Center
Beachwood, Ohio, United States
Amy Brenner MD & Associates
Mason, Ohio, United States
Chattanooga Medical Research LLC
Chattanooga, Tennessee, United States
University of Utah
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
FemBloc Study Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-100-007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.